A proteinogenic amino acid derivative resulting from reaction of L-threonine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-threonine by a heteroatom.
ChEBI ID: 84189
Member | Definition | Role |
---|---|---|
4-chlorothreonine | A chloroamino acid that is L-threonine in which one of the hydrogens of the terminal methyl group has been replaced by a chlorine. | 4-chloro-L-threonine |
4-fluorothreonine | 4-fluoro-L-threonine zwitterion; 4-fluoro-L-threonine | |
7-mercaptoheptanoylthreonine phosphate | coenzyme B | |
chir 090 | An L-threonine derivative obtained by formal condensation of the carboxy group of 4-({4-[(morpholin-4-yl)methyl]phenyl}ethynyl)benzoic acid with the amino group of N-hydroxy-L-threoninamide. | CHIR-090 |
hydroxythreonine | A hydroxy-amino acid consisting of L-threonine having a hydroxy substituent at the 4-position. | 4-hydroxy-L-threonine zwitterion; 4-hydroxy-L-threonine |
n-acetylthreonine | A N-acetyl-L-amino acid that is the N-acetyl derivative of L-threonine. | N-acetyl-L-threonine |
n(6)-(n-threonylcarbonyl)adenosine | An N-(adenosin-N(6)-ylcarbonyl)threonine in which the threonine portion has L-configuration. | N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonine |
o-methyl threonine | An L-threonine derivative that is L-threonine with a methyl group replacing the hydrogen on the hydroxy side chain. | O-methyl-L-threonine |
phosphothreonine | A L-threonine derivative phosphorylated at the side-chain hydroxy function. | O-phospho-L-threonine |
tabtoxin | A monobactam phytotoxic dipeptide produced by Pseudomonas syringae, that causes wildfire disease in tobacco. | tabtoxin |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 163 (12.06) | 18.7374 |
1990's | 384 (28.40) | 18.2507 |
2000's | 434 (32.10) | 29.6817 |
2010's | 314 (23.22) | 24.3611 |
2020's | 57 (4.22) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 52 (3.64%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 1,377 (96.36%) | 84.16% |